CIK: 0001388325 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Oct 24, 2024
Total Value ($000): $2,013,443 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDS | 1,038,550 | $294,076 | 14.6% | $267.51 | — | TOTAL STK MKT | 922908769 |
| TEM | TEMPUS AI INC | 4,074,419 | $230,612 | 11.5% | $30.66 | +52.5% | CL A | 88023B103 |
| BN | BROOKFIELD CORP | 3,491,230 | $185,559 | 9.2% | $22.16 | +41.2% | CL A LTD VT SH | 11271J107 |
| EWTX | EDGEWISE THERAPEUTICS INC | 5,549,900 | $148,127 | 7.4% | $17.44 | +14.1% | COM | 28036F105 |
| CORT | CORCEPT THERAPEUTICS INC | 2,411,362 | $111,598 | 5.5% | $23.02 | +54.4% | COM | 218352102 |
| ASML | ASML HOLDING N V | 133,336 | $111,102 | 5.5% | $654.82 | — | N Y REGISTRY SHS | N07059210 |
| CRM | SALESFORCE INC | 368,560 | $100,879 | 5.0% | $193.03 | +31.5% | COM | 79466L302 |
| PCVX | VAXCYTE INC | 750,000 | $85,703 | 4.3% | $31.07 | +190.1% | COM | 92243G108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,500,000 | $58,500 | 2.9% | $12.27 | +225.2% | COM | 604749101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,385,000 | $54,259 | 2.7% | $16.80 | -2.7% | COM | 92790C104 |
| BABA | ALIBABA GROUP HLDG LTD | 500,827 | $53,148 | 2.6% | $165.09 | — | SPONSORED ADS | 01609W102 |
| INSM | INSMED INC | 724,666 | $52,901 | 2.6% | $23.10 | +219.4% | COM PAR $.01 | 457669307 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,000,000 | $51,100 | 2.5% | $19.36 | +166.3% | COM | 22663K107 |
| CABO | CABLE ONE INC | 118,403 | $41,416 | 2.1% | $987.67 | -64.6% | COM | 12685J105 |
| AVBP | ARRIVENT BIOPHARMA INC | 1,505,315 | $35,375 | 1.8% | $19.51 | +16.3% | COM | 04272N102 |
| — | MERUS N V | 700,000 | $34,972 | 1.7% | $58.84 | — | COM | N5749R100 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 490,000 | $34,442 | 1.7% | $84.22 | -0.8% | COM | 09061G101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 963,663 | $32,755 | 1.6% | $37.78 | +0.9% | COM NEW | 15117B202 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 118,383 | $32,559 | 1.6% | $160.04 | +62.7% | COM | 02043Q107 |
| PHVS | PHARVARIS N V | 1,725,000 | $31,947 | 1.6% | $15.26 | +19.7% | COM | N69605108 |
| — | LANZATECH GLOBAL INC | 15,814,845 | $30,206 | 1.5% | $3.88 | — | COM | 51655R101 |
| BAM | BROOKFIELD ASSET MANAGMT LTD | 627,207 | $29,661 | 1.5% | $31.11 | +28.9% | CL A LMT VTG SHS | 113004105 |
| — | CARGO THERAPEUTICS INC | 1,544,000 | $28,487 | 1.4% | $21.87 | — | COM | 14179K101 |
| FOLD | AMICUS THERAPEUTICS INC | 2,500,000 | $26,700 | 1.3% | $12.83 | -15.1% | COM | 03152W109 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,100,000 | $20,317 | 1.0% | $28.09 | -27.1% | COM | 77313F106 |
| ZBIO | ZENAS BIOPHARMA INC | 1,150,000 | $19,458 | 1.0% | $17.98 | 0.0% | COM | 98937L105 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 1,500,000 | $16,215 | 0.8% | $17.55 | -5.4% | COM | 35104E100 |
| — | BLUEPRINT MEDICINES CORP | 175,000 | $16,188 | 0.8% | $59.75 | — | COM | 09627Y109 |
| — | VERVE THERAPEUTICS INC | 2,400,000 | $11,616 | 0.6% | $12.43 | — | COM | 92539P101 |
| LXEO | LEXEO THERAPEUTICS INC | 1,122,581 | $10,148 | 0.5% | $13.07 | -8.8% | COM | 52886X107 |
| KYTX | KYVERNA THERAPEUTICS INC | 1,850,000 | $9,047 | 0.4% | $19.62 | -60.7% | COM | 501976104 |
| MGX | METAGENOMI INC | 1,800,000 | $3,906 | 0.2% | $11.34 | -69.4% | COM | 59102M104 |
| IOBT | IO BIOTECH INC | 3,354,449 | $3,522 | 0.2% | $6.26 | -79.9% | COM | 449778109 |
| ABCL | ABCELLERA BIOLOGICS INC | 1,126,915 | $2,930 | 0.1% | $8.47 | -67.3% | COM | 00288U106 |
| MQ | MARQETA INC | 441,558 | $2,172 | 0.1% | $22.37 | -76.6% | CLASS A COM | 57142B104 |
| GLTO | GALECTO INC | 99,913 | $1,214 | 0.1% | $13.05 | 0.0% | COM NEW | 36322Q206 |
| SPRO | SPERO THERAPEUTICS INC | 468,902 | $628 | 0.0% | $11.41 | -88.3% | COM | 84833T103 |